Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument

Affiliations

¹ Research & Policy, European Asthma Research & Innovation Partnership, Asthma UK, London, UK.
² Swiss Institute of Allergy and Asthma Research (SIAF), Medical Faculty, University of Zurich, Zurich, Switzerland.
³ Asthma and Allergy Research, IMM Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Medicine, Southampton NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, UK.
⁵ Department of Paediatrics, Paediatric Respiratory and Allergy Units, Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain.
⁶ Department of Respiratory Medicine, Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, UK.
⁷ Medical University of Łódź, Łódź, Poland.
⁸ Respiratory Therapeutic Area, Respiratory Franchise, Novartis Pharmaceuticals, East Hanover, NJ, USA.
⁹ Asthma Clinical Discovery, Respiratory Therapy Area Unit, GlaxoSmithKline, Hertfordshire, UK.
¹⁰ European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
¹¹ Allergy Department, University of Athens, Athens, Greece.
¹² Allergy & Paediatric Allergy, University of Manchester, Manchester, UK.
¹³ European Lung Foundation, Sheffield, UK.

Editorial

S M Walker et al. Clin Exp Allergy. 2016 Sep.

. 2016 Sep;46(9):1136-8.

doi: 10.1111/cea.12779.

¹ Research & Policy, European Asthma Research & Innovation Partnership, Asthma UK, London, UK.
² Swiss Institute of Allergy and Asthma Research (SIAF), Medical Faculty, University of Zurich, Zurich, Switzerland.
³ Asthma and Allergy Research, IMM Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Medicine, Southampton NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, UK.
⁵ Department of Paediatrics, Paediatric Respiratory and Allergy Units, Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain.
⁶ Department of Respiratory Medicine, Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, UK.
⁷ Medical University of Łódź, Łódź, Poland.
⁸ Respiratory Therapeutic Area, Respiratory Franchise, Novartis Pharmaceuticals, East Hanover, NJ, USA.
⁹ Asthma Clinical Discovery, Respiratory Therapy Area Unit, GlaxoSmithKline, Hertfordshire, UK.
¹⁰ European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
¹¹ Allergy Department, University of Athens, Athens, Greece.
¹² Allergy & Paediatric Allergy, University of Manchester, Manchester, UK.
¹³ European Lung Foundation, Sheffield, UK.

No abstract available

Publication types